Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.
Manickam PonnaiahSivaraman GanesanTarun BhatnagarMahalakshmy ThulasingamMarie Gilbert MajellaMathan KaruppiahS A RizwanArun AlexanderSonali SarkarSitanshu Sekhar KarTamilarasu KadhiravanAparna BhatnagarPrasanna Kumar SVivekanandan M PillaiPradeep Pankajakshan NairRahul DhodapkarPampa Ch ToiRakesh SinghNirupama KasthuriGirish C P KumarSaranya JaisankarVaibhav SainiAnkita KankariaAnuradha RajAmit GoyalVidhu SharmaSatyendra KhicharKapil SoniMahendra Kumar GargKalaiselvi SelvarajShriKrishna B HKranti BhavanaBhartendu BhartiC M SinghNeha ChaudharyVijayaravindh RGopinath KKarthikeyan PalaninathanSimmi DubeRita Singh SaxenaNikhil GuptaA RathinavelS Priyanull ArulsundareshkumarShama A BelladAvinash KaviAnilkumar S HarugopKailesh PujaryKirthinath BallalaSneha Deepak MallyaHanumanth M PrasadD RaviN K BalajiRaghuraj HegdeNeha MishraShalina RayS KarthikeyanSudha RamalingamA MuraliSudhakar VaidyaMohit SamadhiyaDhaval BhojaniSomu LakshmananSudagar R B SinghNataraj PillaiP DeepthiK BanumathiV SumathiD RameshSonam Poonam NissarKhushnood M SheikhManisha N PatelVipul ShristavaSuresh S KumarK ShantaramanRajkamal D PandianManoj MurhekarRakesh AggarwalPublished in: PloS one (2022)
Hyperglycemia, irrespective of having diabetes mellitus and steroid use, was associated with an increased risk of ROCM independent of COVID-19 hospitalisation. Rational steroid usage and glucose monitoring may reduce the risk of post-COVID.